Seeking to enhance its sample preparation and enzyme portfolio, Illumina
Inc. announced Jan. 11 that it has acquired Epicentre Biotechnologies, a provider of nucleic acid sample preparation reagents and specialty enzymes used in
sequencing and microarray applications.
Under this new agreement, Janssen—which took an equity stake in Biocartis last year—will have worldwide exclusive rights to develop and
commercialize assays on Biocartis’ MDx platform in the fields of neurological disease and certain viral infectious diseases
We not only need to educate our own children and young adults to be more skilled in
scientific and other advanced fields, but also need to figure out how to keep more of the people who come to study in the United States from abroad
Sometimes, keeping it too simple works against forward progress. While there is no need to make things unnecessarily complicated, we must work to
ensure we don't dumb things down so much that people expect easy solutions, accept weak ones or buy into faulty conclusions.